REGENXBIO Inc. (RGNX) Form 10-Q Quarterly Reports
REGENXBIO Inc. (RGNX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RGNX
CIK: 1590877
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJohnnie Lewis
Audit LocationWashington, District of Columbia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-14 | 8-K | 0001193125-26-423376 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-13 | — | SCHEDULE 13G Filing | 0000019617-26-000350 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-23 | 8-K | 0001193125-26-399377 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | PRIMARY DOCUMENT | 0002062007-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | PRIMARY DOCUMENT | 0001789335-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | PRIMARY DOCUMENT | 0002023732-26-000008 | View SEC Doc Filr Page |
| 3 | 2026-08-27 | 2026-08-25 | PRIMARY DOCUMENT | 0002023732-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-25 | 8-K | 0001193125-26-365287 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-24 | 8-K | 0001193125-26-363786 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-336725 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336716 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-01 | PRIMARY DOCUMENT | 0001700659-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-01 | PRIMARY DOCUMENT | 0001521123-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-16 | 8-K | 0001193125-26-308342 | View SEC Doc Filr Page |
| 424B5 | 2026-07-17 | — | 424B5 | 0001193125-26-308027 | View SEC Doc Filr Page |
| FWP | 2026-07-17 | — | FWP | 0001193125-26-306576 | View SEC Doc Filr Page |
| 424B5 | 2026-07-16 | — | 424B5 | 0001193125-26-306170 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2025-12-31 | PRIMARY DOCUMENT | 0001346164-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-02 | PRIMARY DOCUMENT | 0001700659-26-000014 | View SEC Doc Filr Page |
| SC TO-I/A | 2026-07-06 | — | SC TO-I/A | 0001193125-26-295587 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001700659-26-000012 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001950047-26-006719 | View SEC Doc Filr Page |
| SC TO-I/A | 2026-07-01 | — | SC TO-I/A | 0001193125-26-291681 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-23 | 8-K | 0001193125-26-286825 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-04 | — | SCHEDULE 13G/A Filing | 0000019617-26-000236 | View SEC Doc Filr Page |